Please login to the form below

Not currently logged in
Email:
Password:

Pharmaceutical

This page shows the latest Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.

Europe closer to biosimilar rule change, despite fierce resistance from pharma

Europe closer to biosimilar rule change, despite fierce resistance from pharma

The European Union is a step closer to introducing new rules aimed at boosting exports of generics and biosimilars from the region – despite dogged opposition from the pharmaceutical industry. ... The European Commission has a very contrasting view,

Latest news

  • China approves Ironwood Pharma’s IBS treatment China approves Ironwood Pharma’s IBS treatment

    Coincides with AZ's Mark Mallon taking over as CEO. Ironwood Pharmaceuticals’ irritable bowel syndrome treatment Linzess has gained approval in China, opening up a market of up to 14m adults ... Mark Mallon, CEO, Ironwood Pharmaceuticals and Cyclerion.

  • Industry pleads for compromise after Brexit defeat Industry pleads for compromise after Brexit defeat

    The Association of the British Pharmaceutical Industry (ABPI) chief executive Mike Thompson said that no-deal would be “extremely challenging” and raises the risk that access to medicines may be disrupted ... The focus of pharmaceutical companies is

  • Global ban on pharma freebies, including cultural gifts Global ban on pharma freebies, including cultural gifts

    It’s not just what pharmaceutical innovation achieves that matters, but also how the industry goes about achieving it. ... Many multinational pharmaceutical companies such as Pfizer, AstraZeneca and Novartis have already instituted global bans on gifts

  • AZ’s Sean Bohen to exit after business overhaul; report AZ’s Sean Bohen to exit after business overhaul; report

    Chief commercial officer Mark Mallon has taken on the CEO role at US biotech Ironwood Pharmaceuticals, while Medimmune research head Bahija Jallal agreed to take the helm of UK biotech company

  • Time running out for ‘no-deal’ Brexit medicines laws Time running out for ‘no-deal’ Brexit medicines laws

    However the General Pharmaceutical Council (GPhC) has argued against the latter, claiming that it could put patient safety at risk as prescribers may no longer be qualified to do so in

More from news
Approximately 84 fully matching, plus 2,807 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 576 partially matching documents found.

Latest appointments

More from appointments
Approximately 54 fully matching, plus 694 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 34 fully matching, plus 963 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics